Spruce Biosciences Inc. (NASDAQ: SPRB) Stock Information

Drug Name	Stage
TildacerfontDetailsCongenital adrenal hyperplasia, Primary biliary cholangitis, Liver diseaseBig Mover™Suspected Mover™Susp. Mover™	Phase 2
TildacerfontDetailsCongenital adrenal hyperplasia	Phase 2
TildacerfontDetailsPolycystic ovary syndrome	Phase 2

Drug Name

Stage

TildacerfontDetailsCongenital adrenal hyperplasia, Primary biliary cholangitis, Liver diseaseBig Mover™Suspected Mover™Susp. Mover™

Phase 2

TildacerfontDetailsCongenital adrenal hyperplasia

Phase 2

TildacerfontDetailsPolycystic ovary syndrome

Phase 2

Open	$50.03
Previous Close	$49.05
Volume	0.7K
Market Cap	$135.00M
Day Range	$49.38 - $50.03
52 Week Range	$4.35 - $240.00
Shares Outstanding	2.75M
Change %	+2.00%
Net Change	▲ 0.9790
Insider Ownership	-0.06%
Exchange	NASDAQ
Sector	Healthcare
Industry	Medicinal Chemicals and Botanical Products
IPO Year	2020
Country	United States
Underwriter	IPO Intelligence Only

Date	Type	Amount Purchased	Purchaser
2025-10-15	Buy	256.00	Parkman Healthcare Partners LLC
2025-10-15	Buy	256.00	Parkman Healthcare Partners LLC
2025-10-08	Buy	256.00	Parkman Healthcare Partners LLC
2025-10-08	Buy	256.00	Parkman Healthcare Partners LLC
2025-10-08	Buy	256.00	Parkman Healthcare Partners LLC
2024-05-24	Sale	-30000.00	Ways Kirk
2024-05-24	Sale	-30000.00	SIMPSON CAMILLA V
2024-05-24	Sale	-30000.00	Muralidhar Bali
2024-05-24	Sale	-30000.00	Barretto-Ko Percival
2024-05-24	Sale	-30000.00	GREY MICHAEL G

Date

Type

Amount Purchased

Purchaser

2025-10-15

Buy

256.00